nach oben

Journal of Endocrinological Investigation

Erschienen in:

01.03.2019 | Original Article

Circulating insulin-like peptide 5 levels and its association with metabolic and hormonal parameters in women with polycystic ovary syndrome

verfasst von: M. Bicer, M. Alan, P. Alarslan, A. Guler, G. U. Kocabas, C. Imamoglu, M. Aksit, G. Bozkaya, A. M. Isil, A. Baloglu, B. Aslanipoiur, Mehmet Calan

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Insulin-like peptide 5 (INSL5) is a gut peptide hormone that is a member of relaxin/insulin superfamily. Growing evidence implicates the crucial role of the peptide in some metabolisms including food intake, glucose homeostasis and reproductive system. Polycystic ovary syndrome (PCOS) is involved in both reproductive and metabolic issues. The aim of the study was determination of circulating levels of INSL5 alteration in women with PCOS and evaluation of the relationship between INSL5 and hormonal-metabolic parameters as well as carotid intima media thickness (cIMT).

Methods

A total of 164 subjects were recruited in this cross-sectional study (82 women with PCOS and 82 age- and BMI-matched controls). Circulating INSL5 levels were assessed via ELISA method. High-resolution B-mode ultrasound was used to measure cIMT. The hormonal and metabolic parameters of the recruited subjects were determined.

Results

Circulating INSL5 levels were significantly elevated in women with PCOS compared to controls (27.63 ± 7.74 vs. 19.90 ± 5.85 ng/ml, P < 0.001). The mean values of INSL5 were significantly higher in overweight subjects compared to lean weight subjects in both groups. The women with PCOS having insulin resistance have increased INSL5 compared to those of PCOS subjects without insulin resistance. INSL5 is associated with insulin resistance, BMI, luteinizing hormone and free androgen index. Multivariate logistic regression analyses revealed that the odds ratio for having PCOS in the highest tertile of INSL5 was higher than in the lowest tertile.

Conclusions

PCOS subjects exhibited an elevation in circulating INSL5 levels along with a link between INSL5 level induction and metabolic-hormonal parameters.

Ehrmann DA (2005) Polycystic ovary syndrome. N Engl J Med 352:1223–1236. https://doi.org/10.1056/NEJMra041536 CrossRefPubMed

Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745–2749. https://doi.org/10.1210/jc.2003-032046 CrossRefPubMed

March WA, Moore VM, Willson KJ, Phillips DIW, Norman RJ, Davies MJ (2010) The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 25:544–551. https://doi.org/10.1093/humrep/dep399 CrossRefPubMed

Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF et al (2013) Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod 28:777–784. https://doi.org/10.1093/humrep/des463 CrossRefPubMed

Christian RC, Dumesic DA, Behrenbeck T, Oberg AL, Sheedy PF, Fitzpatrick LA (2003) Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:2562–2568CrossRefPubMed

Orio F, Palomba S, Spinelli L, Cascella T, Tauchmanovà L, Zullo F et al (2004) The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. J Clin Endocrinol Metab 89:3696–3701. https://doi.org/10.1210/jc.2003-032049 CrossRefPubMed

Conklin D, Lofton-Day CE, Haldeman BA, Ching A, Whitmore TE, Lok S et al (1999) Identification of INSL5, a New Member of the insulin superfamily. Genomics 60:50–56. https://doi.org/10.1006/geno.1999.5899 CrossRefPubMed

Dun SL, Brailoiu E, Wang Y, Brailoiu GC, Liu-Chen L-Y, Yang J et al (2006) Insulin-like peptide 5: expression in the mouse brain and mobilization of calcium. Endocrinology 147:3243–3248. https://doi.org/10.1210/en.2006-0237 CrossRefPubMed

Burnicka-Turek O, Mohamed BA, Shirneshan K, Thanasupawat T, Hombach-Klonisch S, Klonisch T et al (2012) INSL5-deficient mice display an alteration in glucose homeostasis and an impaired fertility. Endocrinology 153:4655–4665. https://doi.org/10.1210/en.2012-1161 CrossRefPubMed

10.

Mashima H, Ohno H, Yamada Y, Sakai T, Ohnishi H (2013) INSL5 may be a unique marker of colorectal endocrine cells and neuroendocrine tumors. Biochem Biophys Res Commun 432:586–592. https://doi.org/10.1016/j.bbrc.2013.02.042 CrossRefPubMed

11.

Hu M-J, Wei D, Shao X-X, Wang J-H, Liu Y-L, Xu Z-G et al (2017) Interaction mechanism of insulin-like peptide 5 with relaxin family peptide receptor 4. Arch Biochem Biophys 619:27–34. https://doi.org/10.1016/j.abb.2017.03.001 CrossRefPubMed

12.

Grosse J, Heffron H, Burling K, Akhter Hossain M, Habib AM, Rogers GJ et al (2014) Insulin-like peptide 5 is an orexigenic gastrointestinal hormone. Proc Natl Acad Sci USA 111:11133–11138. https://doi.org/10.1073/pnas.1411413111 CrossRefPubMed

13.

Luo X, Li T, Zhu Y, Dai Y, Zhao J, Guo Z-Y et al (2015) The insulinotrophic effect of insulin-like peptide 5 in vitro and in vivo. Biochem J 466:467–473. https://doi.org/10.1042/BJ20141113 CrossRefPubMed

14.

Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19(1):41–47. https://doi.org/10.1093/humrep/deh098 CrossRef

15.

Ferriman D, Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440–1447. https://doi.org/10.1210/jcem-21-11-1440 CrossRefPubMed

16.

Al Kindi MK, Al Essry FS, Al Essry FS, Mula-Abed W-AS (2012) Validity of serum testosterone, free androgen index, and calculated free testosterone in women with suspected hyperandrogenism. Oman Med J 27:471–474. https://doi.org/10.5001/omj.2012.112 CrossRefPubMedPubMedCentral

17.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed

18.

Sidhu PS, Desai SR (1997) A simple and reproducible method for assessing intimal-medial thickness of the common carotid artery. Br J Radiol 70:85–89. https://doi.org/10.1016/0929-8266(96)88371-6 CrossRefPubMed

19.

Faul F, Erdfelder E, Lang A-G, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175–191. https://doi.org/10.3758/BF03193146 CrossRefPubMed

20.

Geloneze B, Repetto EM, Geloneze SR, Tambascia MA, Ermetice MN (2006) The threshold value for insulin resistance (HOMA-IR) in an admixtured population. IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract 72:219–220. https://doi.org/10.1016/j.diabres.2005.10.017 CrossRefPubMed

21.

Spanel-Borowski K, Schäfer I, Zimmermann S, Engel W, Adham IM (2001) Increase in final stages of follicular atresia and premature decay of corpora lutea in Insl3-deficient mice. Mol Reprod Dev 58:281–286. https://doi.org/10.1002/1098-2795(200103)58:3<281:AID-MRD6>3.0.CO;2-0

22.

Irving-Rodgers HF, Bathgate RAD, Ivell R, Domagalski R, Rodgers RJ (2002) Dynamic changes in the expression of relaxin-like factor (INSL3), cholesterol side-chain cleavage cytochrome p450, and 3beta-hydroxysteroid dehydrogenase in bovine ovarian follicles during growth and atresia. Biol Reprod 66:934–943CrossRefPubMed

23.

Satchell L, Glister C, Bleach EC, Glencross RG, Bicknell AB, Dai Y et al (2013) Ovarian expression of insulin-like peptide 3 (INSL3) and its receptor (RXFP2) during development of bovine antral follicles and corpora lutea and measurement of circulating INSL3 levels during synchronized estrous cycles. Endocrinology 154:1897–1906. https://doi.org/10.1210/en.2012-2232 CrossRefPubMed

24.

Anand-Ivell R, Tremellen K, Dai Y, Heng K, Yoshida M, Knight PG et al (2013) Circulating insulin-like factor 3 (INSL3) in healthy and infertile women. Hum Reprod 28:3093–3102. https://doi.org/10.1093/humrep/det349 CrossRefPubMed

25.

Pelusi C, Fanelli F, Pariali M, Zanotti L, Gambineri A, Pasquali R (2013) Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern. J Clin Endocrinol Metab 98:E1575–E1582. https://doi.org/10.1210/jc.2013-1107 CrossRefPubMed

26.

Gambineri A, Patton L, De Iasio R, Palladoro F, Pagotto U, Pasquali R (2007) Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome. J Clin Endocrinol Metab 92:2066–2073. https://doi.org/10.1210/jc.2006-1678 CrossRefPubMed

27.

Wagner IV, Flehmig G, Scheuermann K, Löffler D, Körner A, Kiess W et al (2016) Insulin-like peptide 5 interacts with sex hormones and metabolic parameters in a gender and adiposity dependent manner in humans. Horm Metab Res 48:589–594. https://doi.org/10.1055/s-0042-109869 CrossRefPubMed

28.

Lee YS, De Vadder F, Tremaroli V, Wichmann A, Mithieux G, Bäckhed F (2016) Insulin-like peptide 5 is a microbially regulated peptide that promotes hepatic glucose production. Mol Metab 5:263–270. https://doi.org/10.1016/j.molmet.2016.01.007 CrossRefPubMedPubMedCentral

29.

Diamanti-Kandarakis E, Dunaif A (2012) Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 33:981–1030. https://doi.org/10.1210/er.2011-1034 CrossRefPubMedPubMedCentral

30.

Dunaif A, Segal KR, DA Futterweit W (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165–1174CrossRefPubMed

31.

Järvisalo MJ, Harmoinen A, Hakanen M, Paakkunainen U, Viikari J, Hartiala J et al (2002) Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol 22:1323–1328. https://doi.org/10.1161/01.ATV.0000024222.06463.21 CrossRefPubMed

32.

Polak JF, Szklo M, Kronmal RA, Burke GL, Shea S, Zavodni AEH et al (2013) The value of carotid artery plaque and intima-media thickness for incident cardiovascular disease: the multi-ethnic study of atherosclerosis. J Am Heart Assoc 2:e000087–e000087. https://doi.org/10.1161/JAHA.113.000087 CrossRefPubMedPubMedCentral

33.

O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:14–22. https://doi.org/10.1056/NEJM199901073400103 CrossRefPubMed

Titel: Circulating insulin-like peptide 5 levels and its association with metabolic and hormonal parameters in women with polycystic ovary syndrome
verfasst von: M. Bicer
M. Alan
P. Alarslan
A. Guler
G. U. Kocabas
C. Imamoglu
M. Aksit
G. Bozkaya
A. M. Isil
A. Baloglu
B. Aslanipoiur
Mehmet Calan
Publikationsdatum: 01.03.2019
Verlag: Springer International Publishing
Erschienen in: Journal of Endocrinological Investigation / Ausgabe 3/2019
Elektronische ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-018-0917-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Follow-up of parenchymal changes in the thyroid gland with diffuse autoimmune thyroiditis in children prior to the development of papillary thyroid carcinoma

Identification a novel insertion PHEX mutation in a sporadic patient with hypophosphatemic rickets

Can combination of glucocorticoids with other immunosoppressive drugs reduce the cumulative dose of glucocorticoids for moderate-to-severe and active Graves’ orbitopathy?

Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study

The diagnostic accuracy of increased late night salivary cortisol for Cushing’s syndrome: a real-life prospective study